Precision's Comprehensive Tumor Profiles offer a portfolio of products developed to help guide physicians and patients with difficult clinical decisions throughout the Cancer Care Continuum.
Precision’s ongoing array of multiple products and technologies provide unique clinical value through a Comprehensive Tumor Profile, which includes: ChemoFx®
and GeneFx Colon®
. This approach to precision medicine combines genomic expression and molecular information specific and clinically relevant to a patient’s cancer, answering a broad range of clinical questions that physicians encounter every day while managing their patient’s care.
Precision Therapeutics is now HelomicsTM
Like Precision, Helomics is dedicated to improving the outcomes of cancer patients by providing personalized healthcare solutions that aim to increase quality of life and cancer survival rates.